Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-326-3 | CAS number: 105-74-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Apparently well conducted study
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
Test material
- Reference substance name:
- Dilauroyl peroxide
- EC Number:
- 203-326-3
- EC Name:
- Dilauroyl peroxide
- Cas Number:
- 105-74-8
- Molecular formula:
- C24H46O4
- IUPAC Name:
- dodecanoyl dodecaneperoxoate
- Reference substance name:
- Laurox
- IUPAC Name:
- Laurox
- Details on test material:
- A consignment of 100 g (net) Laurox, white flakes, was received from the Sponsor on 2 October 1992. The test material was further identified by the
Batch No. 0029209020111, the CAS No. 105-74-8 and the EINECS No. 2033263. It was stated Dilauroyl peroxide and was 99.7% pure.
It was stored in a refrigerator (approximately 4°C), in the original container. The identity, strength and purity of the test material received, and its
stability under the storage conditions above, were the responsibility of the Sponsor. A certificate of analysis for the batch of test material used
on this study is presented in Appendix 1.
Constituent 1
Constituent 2
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- Young albino rabbits of an outbred New Zealand White strain were supplied by Rosemead Rabbits, Rosemead, Waltham Abbey, Essex, England. They
were individually housed in suspended stainless steel cages mounted in mobile batteries (Modular Systems and Development Company limited,
London, England). The cages were fitted with perforated counter-sunk floor panels. A tray beneath the floor was lined with absorbent paper which was
changed regularly. Animals had free access to a commercially available standard pelleted rabbit diet (S.Q.C. Rabbit Diet, Special Diets Services
Limited, Witham, Essex, England). The rabbits had free access to tap water taken from the public supply; in England the supply and quality of this water is
governed by Department of the Environment regulations. Results of these analyses are retained in the archives. There was no information indicating
that normal levels of common contaminants, or specific contaminants, in the diet or drinking water would influence the outcome of the study.
The animals were housed in a lagomorph room within a limited-access building. The room was kept at slight positive pressure relative to the outside and had its own filtered air supply giving approximately 15 complete air changes per hour without re-circulation. A temperature range of 18-22°C
and a relative humidity range of 45-56% R.H. Electric time-switches operated a lighting cycle of 12 hours of artificial light per day. An emergency
generator was available to maintain the electricity supply in the event of a power failure.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: The untreated eye served as a control
- Amount / concentration applied:
- 0.1 gram
- Duration of treatment / exposure:
- One instillation
- Observation period (in vivo):
- 7 days
- Number of animals or in vitro replicates:
- 3
- Details on study design:
- Each rabbit was inspected on arrival and unsuitable individuals were rejected. Individual bodyweight was recorded for each animal on the day of
receipt and at weekly intervals thereafter. All animals were identified by a uniquely numbered ear-tag. During the acclimatization period, the health
status of each animal was monitored and a record kept. This record was consulted before an animal was allocated to study. Both eyes of each animal were examined before administration of the test material for signs of pre-existing irritation, reaction or abnormality which would prevent it from
being used on the study. Each cage was labelled with details of the schedule number, ear-tag number, sex, administration, treatment level,
Bodyweights on the day of dosing were within the range 3.04 - 4.52 kg. The rabbits were approximately either three or six months old at this time.
Each animal was gently restrained. The dose was instilled into the right eye by pulling the lower eye lid away from the eyeball to form a cup into
which 0.1 g of the test material was dropped. The eyelids were gently held together for one second and then released. The left eye remained
untreated.
The behaviour of each rabbit was observed for several minutes immediately following instillation of the test material to allow assessment of the initial pain response.
The animals were returned to their cages and checked at least twice during the first hour after dosing, at regular intervals throughout the day and
daily to ensure that the treated eye was not subject to infection or causing distress. Ocular reactions to treatment were assessed 1, 24, 48 and 72
hours after treatment. Reactions not included below were described in detail. Additional observations of persistent ocular lesions or irritation
responses were made seven days after treatment. The untreated eye was used as a comparison with the treated eye during assessment of ocular
lesions. An ophthalmoscope was used to facilitate inspection of the eyes.
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Remarks on result:
- other: see table
- Irritation parameter:
- iris score
- Remarks on result:
- other: see table
- Irritation parameter:
- conjunctivae score
- Remarks on result:
- other: see table
- Irritation parameter:
- chemosis score
- Remarks on result:
- other: see table
- Irritant / corrosive response data:
- A diffuse crimson~red conjunctival appearance or injection of the conjunctival blood vessels was observed in all rabbits during the first 24 hours
following instillation, continuing in one animal to the 48 hour examination and in another up to the 72 hour examination. Very slight chemosis and
very slight or slight discharge were observed during the first 24 hours after treatment. The test eyes of two rabbits were overtly normal at the 72
hour examination; that of the remaining rabbit had recovered by the seventh day. Instillation of the test material caused practically no initial pain
response. - Other effects:
- None
Any other information on results incl. tables
Summary of Ocular Lesions
Anim. No. |
Effect |
Hours |
Hours after application |
Days after application |
Mean score cornea 24, 48, 72 hrs |
Mean score iritis 24, 48, 72 hrs |
Mean score redness 24, 48, 72 hrs. |
Mean score chemosis 24, 48, 72 hrs. |
|||
1 |
24 |
48 |
72 |
4 |
7 |
||||||
1 |
Cornea Iris Redness Chemosis Discharge Pain* |
0 0 1 0 1 1 |
0 0 1 0 0 |
0 0 0 0 0 |
0 0 0 0 0 |
0 |
0 |
0.3 |
0 |
||
2 |
Cornea Iris Redness Chemosis Discharge Pain* |
0 0 1 1 1 0 |
0 0 1 0 1 |
0 0 1 0 0 |
0 0 0 0 0 |
0 |
0 |
0.7 |
0 |
||
3 |
Cornea Iris Redness Chemosis Discharge Pain* |
0 0 2 1 2 1 |
0 0 2 0 0 |
0 0 1 0 0 |
0 0 1 1 0 |
0 0 0 0 0 |
0 |
0 |
1.3 |
0 |
*Evaluated upon instillation
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- A diffuse crimson~red conjunctival appearance or injection of the conjunctival blood vessels was observed in all rabbits during the first 24 hours
following instillation, continuing in one animal to the 48 hour examination and in another up to the 72 hour examination. Very slight chemosis and
very slight or slight discharge were observed during the first 24 hours after treatment. The test eyes of two rabbits were overtly normal at the 72
hour examination; that of the remaining rabbit had recovered by the seventh day. Instillation of the test material caused practically no initial pain
response. According to GHS, Laurox is not classified as an eye irritant. - Executive summary:
Laurox was evaluated for potential eye irritation following the instillation of 0.1 gram into rabbit eyes In accordance with OECD 405. Response to pain was evaluated upon instillation. Ocular reactions were evaluated 1, 24, 48 and 72 hours and 7 days following instillation.
A diffuse crimson~red conjunctival appearance or injection of the conjunctival blood vessels was observed in all rabbits during the first 24 hours following instillation, continuing in one animal to the 48 hour examination and in another up to the 72 hour examination. Very slight chemosis and very slight or slight discharge were observed during the first 24 hours after treatment. The test eyes of two rabbits were overtly normal at the 72 hour examination; that of the remaining rabbit had recovered by the seventh day. Instillation of the test material caused practically no initial pain response.
According to GHS, Laurox is not classified as an eye irritant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.